Skip to content

Author

K. Siontis

We have 5 of 201 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Ventricular Pulsed Field Ablation: State-of-the-art Review of Preclinical and Clinical Evidence

Pulsed field ablation (PFA) is a paradigm shift in the field of cardiac electrophysiology. The well-demonstrated success with atrial PFA is generating enthusiasm for ventricular applications of PFA, for which the clinical experience is still in its infancy, however. This study is a systematic review and critical apprai...

E. Martínez-Gómez, S. Asirvatham, K. Siontis · 0 citations
Nov 2026

Abstract 11135: Ventricular Arrhythmia Outcomes Following Immunosuppression Initiation in Cardiac Sarcoidosis

Introduction: Cardiac sarcoidosis (CS) is an inflammatory cardiomyopathy associated with life-threatening ventricular arrhythmias and heart failure. Although immunosuppressive therapy (IST) remains the cornerstone of treatment, its impact on ventricular arrhythmia risk is not well defined, particularly in the era of...

C. Nouraee, Abdalla Kara Balla, Daniel Sykora et al. · 0 citations
Review Aug 2026

Incidence of Atrial and Ventricular Arrhythmias in Patients With Titin Truncating Variants Across the Ventricular Morphofunctional Phenotypic Spectrum.

BACKGROUND Titin truncating variants (TTNtvs), the most common genetic cause of dilated cardiomyopathy (DCM), are over-represented in early-onset atrial fibrillation (AF) and unexplained sudden cardiac arrest/death (SCA/SCD), suggesting they can cause arrhythmias before development of overt ventricular cardiomyopathy....

R. Coderre, William H. Swain, M. Castrichini et al. · 0 citations
Review Open access Aug 2026

Switching from Vitamin K Antagonists to Direct Oral Anticoagulants in Frail Elderly Patients with Atrial Fibrillation: Systematic Review and Meta-Analysis

Background: Frailty complicates anticoagulation management in older patients with atrial fibrillation (AF), particularly when long-term vitamin K antagonist (VKA) therapy is already established. Whether switching to a direct oral anticoagulant (DOAC) improves outcomes in this setting remains uncertain, and guideline re...

P. Karakasis, Ricardo Gómez-Huelgas, Stylianos Tzeis et al. · 0 citations
Aug 2026

International Experience With Implantable Cardioverter Defibrillators for the Prevention of Sudden Death in High-Risk Patients With Hypertrophic Cardiomyopathy.

In this international multicenter study, the largest to date, including >3300 consecutive patients with HCM and ICDs, device therapy terminated potentially lethal ventricular tachyarrhythmias in 1 of 6 patients, with low HCM-related mortality rates for patients with ICDs.

E. Rowin, B. J. Maron, K. Siontis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.